KnockoutStocks.com stands out as the most comprehensive AI-powered investment platform available in 2026, offering an ...

The removal of advanced data from a popular internet resource has proven unpopular – The Athletic breaks down what happened ...

Spotify Technology (SPOT) is rated 'Buy' for its long-term compounding potential despite a recent 25% stock decline.

StockArkaLytics is committed to continuously enhancing its platform, ensuring that users have access to the latest advancements in AI and stock analysis technology. The launch of StockArkaLytics.com ...

Individuals who invest in the stock market are 50% more likely to start their own business than non-investors, according to ...

Better things are ahead for Club name Eaton after its lackluster 2025 performance. Shares are on track for a modest decline this year, dramatically trailing the S & P 500's industrials sector , which ...

An ambitious data-center project in Utah is going to need about one-quarter of the power the entire state currently uses. David Gray, co-chief executive for the project’s developer, knows he can’t get ...

South Korean e-commerce giant Coupang Inc. (NYSE: CPNG) rose nearly 6% on Friday after the company said its investigation into a former employee suspected of leaking customer data was conducted in ...

Clearwater Analytics (CWAN 0.04%) shares closed Monday’s session at $24.06, up 8.13%. The SaaS solutions provider for investment data aggregation, reconciliation, accounting, and reporting rose on ...

The European Commission has renewed its data adequacy agreement with the UK, guaranteeing free flow of data with the European Union (EU) for a further six years. The agreement assures that the UK’s ...

ThoughtSpot is at the heart of new 'modern data stack' helping UK food brand Huel find answers more quickly than it used to with Business Intelligence Huel, a privately held UK food brand that's all ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...